Immunodominant antiviral T cell responses outcompete immuno-subdominant antitumor responses to reduce the efficacy of oncolytic viroimmunotherapy.
免疫优势的抗病毒 T 细胞反应会抑制免疫劣势的抗肿瘤反应，从而降低溶瘤病毒免疫疗法的疗效
期刊:
影响因子:
doi:10.21203/rs.3.rs-6131273/v1
Vile Richard, Kendall Benjamin, Liseth Olivia, Sangsuwannukul Thanich, Elliott Natalie, Yerovi Maria Chiriboga, Thompson Jill, Swanson Jack, Rizk Soha, Diaz Rosa, Tonne Jason
